Pharma BD Deal Intelligence
Bayer AG / BlueRock Therapeutics
2002 · Acquisition/Merger · $600M · Complete
Announcement Sentiment
88
Strongly positive
Outcome Score
79
Worked — the deal delivered on its rationale.
Bayer acquired remaining 60% stake in BlueRock Therapeutics for ~$600M.
Key facts
- Announced Nov 25, 2002
- Closed Sep 20, 2019
- Deal value $600M
- Deal type Acquisition/Merger
- Therapeutic area Cardiovascular, Gene Therapy, Neurology
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals